nephromax_sheath_family

Register to receive a free U.S. urological devices market report synopsis and brochure

The incidence of bladder cancer cases, genealogical malignancies and urinary calculi is expected to drive the U.S. nephrostomy market to over $110 million by 2020.

According to an in-depth U.S. urology report, from iData Research, the leading global authority in medical device market research, and the U.S. nephrostomy market is expected to approach over $110 million by 2020.  This market includes percutaneous nephrostomy sets, nephrostomy balloon catheters, nephrostomy drainage tubes and ureteral stents. Market growth will be driven by the rise in percutaneous nephrostomy (PCN) procedures.

Growth in procedures will be driven by the incidence of bladder cancer cases, genealogical malignancies and urinary calculi. In 2014 the American Cancer Society’s estimates that there are 74,690 new cases of bladder cancer diagnosed in the United States. The incidence rate of cancer and urinary stones which lead to urinary obstruction will continue to drive PCN procedures and growth in the market.

Nephrostomy balloon catheters will be the fastest growing segment of this market over the next five years.  Growth is driven by percutaneous nephrolithotomy procedure numbers and other cases which necessitate balloon dilation of the ureter. The price of nephrostomy balloon catheters is expected to increase slightly through 2020. As the manufacturing companies continue to innovate and develop new products, the price will show a slight increase over the forecast period; but, competitive pressure will mitigate this effect.

Another factor driving the growth of the nephrostomy market in the U.S. is the increase in in-office procedures. Nephrostomy procedures can be performed in both a doctor’s office and a hospital setting. The doctor’s office setting is beneficial to patients because these procedures allow a higher quality of life, as the setting is more comfortable and the procedure often takes slightly less time.

C.R. Bard, is one of the leading manufacturers in the nephrostomy device market in the United States. Bard’s urology division also has focus on on urological drainage, continence, prostate disease management and skin and wound care. Other notable and key competitors leading the nephrostomy market include Cook Medical, Boston Scientific, Applied Medical and Olympus.

For Further Information

The nephrostomy device market segment is part of the U.S. urological devices market report.  The global report series on the Markets for Urological Devices covers the U.S., Canada, 15 counties in Europe, Japan, India and China. The full reports provide a comprehensive analysis including procedure numbers, units sold, market value, forecasts, as well as a detailed competitive market shares and analysis of major players’ success strategies in each market and segment. The reports cover devices used in the treatment of benign prostate hyperplasia (BPH), prostate cancer, and urinary incontinence as well as urinary and kidney stones. Other markets analyzed include urological endoscopes, urodynamic equipment and nephrostomy devices.

Receive a free synopsis of the U.S. Urological Device 2014 Market Research Report